EUVIMEDEUVIMED entdecken
Crossref

Detection of serum M-protein in acetonitrile precipitates by MALDI-TOF mass spectrometry: A novel, low-cost methodology

Nikita Mehra iD, Gopal Gopisetty iD, Jayavelu Subramani, Sariga Dhanasekar, Arivazhagan Rajamanickam, Jayachandran Perumal Kalaiyarasi iD, Parathan Karunakaran iD, Krishnarathinam Kannan, Swaminathan Rajaraman, Thangarajan Rajkumar

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · 2023-09 · 60 (5) · 339-348

DOI: 10.1177/00045632231174144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, online erschienen am 09.05.2023. Verfasst von Nikita Mehra und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India. Hauptthemen laut MEDLINE: Plasmacytoma, Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, Paraproteinemias. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Several studies have demonstrated the analytical sensitivity of MALDI-TOF mass spectrometry (MALDI-TOF MS) by immunoenrichment for M-protein analysis. We report the results of a novel, low-cost, reagent-based extraction process using acetonitrile (ACN) precipitation to enrich for κ and λ light chains which can be analysed by MALDI-TOF MS.

Methods

Institutional Ethics committee approval was obtained. Serum samples from patients with monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM), plasmacytoma, AL amyloidosis and Waldenström macroglobulinemia (WM) underwent ACN precipitation. The images obtained were overlaid on apparently healthy donor serum samples to confirm the presence of M-protein. A sample was considered positive for M-protein if there was a sharp or broad peak within the κ or λ mass/charge ( m/z) range: m/z- [M + 2H] 2+ : 11,550–12,300 Da and λ m/z- [M + 2H] 2+ : 11,100–11,500 Da. Images were acquired at a m/z range of 10,000–29,000 Da. Corresponding serum protein electrophoresis (SPEP), serum immunofixation electrophoresis (IFE) and serum free light chain (sFLC) assay by nephelometry were performed for all the samples.

Results

Two-hundred-and-two serum samples were included in the study: MM- 184 (91%); AL amyloidosis- 2 (1%); plasmacytoma- 8 (4%); MGUS- 6 (3%) and WM- 2 (1%). All the SPEP positive samples were identified by MALDI-TOF MS. Out of 179 samples positive for M-protein by IFE, MALDI-TOF MS was positive in 176 samples (98%). Compared to IFE, the sensitivity and specificity of M-protein identification by MALDI-TOF MS were 98.3% and 52.2%, respectively.

Conclusions

This study demonstrates the feasibility of qualitatively identifying M-protein without the need for antibody-based immunoenrichment, making the technique cost-effective.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PlasmacytomaImmunoglobulin Light-chain AmyloidosisMultiple MyelomaParaproteinemiasHumansSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationImmunoglobulin Light ChainsAcetonitriles

Stichwörter der Autor:innen

MALDI-TOF mass spectrometryMonoclonal proteinidentificationlight chains

Substanzen

Immunoglobulin Light ChainsAcetonitriles

Autor:innen und Institutionen

  • Department of Medical Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India.
  • Department of Molecular Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India.
  • Department of Biochemistry, Cancer Institute (WIA), Chennai, Tamil Nadu, India.
  • Department of Epidemiology, Biostatistics and Cancer Registry, Cancer Institute (WIA), Chennai, Tamil Nadu, India.

ORCID-Profile: Nikita Mehra, Gopal Gopisetty, Jayachandran Perumal Kalaiyarasi, Parathan Karunakaran

Zitieren

APA

Mehra, N., Gopisetty, G., Subramani, J., Dhanasekar, S., Rajamanickam, A., Perumal Kalaiyarasi, J., Karunakaran, P., Kannan, K., Rajaraman, S., & Rajkumar, T. (2023). Detection of serum M-protein in acetonitrile precipitates by MALDI-TOF mass spectrometry: A novel, low-cost methodology. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 60(5), 339-348. https://doi.org/10.1177/00045632231174144

Vancouver

Mehra N, Gopisetty G, Subramani J, Dhanasekar S, Rajamanickam A, Perumal Kalaiyarasi J, et al. Detection of serum M-protein in acetonitrile precipitates by MALDI-TOF mass spectrometry: A novel, low-cost methodology. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 2023;60(5):339-348. doi:10.1177/00045632231174144

BibTeX
@article{Mehra2023,
  author = {Mehra, Nikita and Gopisetty, Gopal and Subramani, Jayavelu and Dhanasekar, Sariga and Rajamanickam, Arivazhagan and Perumal Kalaiyarasi, Jayachandran and Karunakaran, Parathan and Kannan, Krishnarathinam and Rajaraman, Swaminathan and Rajkumar, Thangarajan},
  title = {Detection of serum M-protein in acetonitrile precipitates by MALDI-TOF mass spectrometry: A novel, low-cost methodology},
  journal = {Annals of Clinical Biochemistry: International Journal of Laboratory Medicine},
  year = {2023},
  volume = {60},
  number = {5},
  pages = {339--348},
  doi = {10.1177/00045632231174144}
}
Kostenlos starten →